With USFDA behind it and a good number of ANDAs in the offing and due for sanction from USFDA in the coming year, it is sure to catapult to much newer heights.
Resistance being at Rs 725 ~ 750, a breather and then a sustained rise to Rs 1050+ cannot be ruled out.
Buy and hold with a stoploss of Rs . 665 or so.
I hope your doubts will be cleared in the coming few weeks.
This scrip is completely bottomed out and selling it will be foolish !!!